Brooks Laboratories Limited Asset Resilience Ratio

Latest as of September 2025: 1.29%

Brooks Laboratories Limited asset resilience ratio. Brooks Laboratories Limited (BROOKS) has an Asset Resilience Ratio of 1.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Brooks Laboratories Limited (BROOKS) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs18.03 Million

≈ $195.02K USD Cash + Short-term Investments

Total Assets

Rs1.40 Billion

≈ $15.13 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Brooks Laboratories Limited (2009–2025)

Asset resilience ratio of Brooks Laboratories Limited from 2009 to 2025. This chart shows how Brooks Laboratories Limited's Asset Resilience Ratio has changed over time. Read BROOKS current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Brooks Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BROOKS current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs299.00K	0.02%
Short-term Investments	Rs17.73 Million	1.27%
Total Liquid Assets	Rs18.03 Million	1.29%

Asset Resilience Insights

Limited Liquidity: Brooks Laboratories Limited maintains only 1.29% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Brooks Laboratories Limited Industry Peers by Asset Resilience Ratio

Compare Brooks Laboratories Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Brooks Laboratories Limited Asset Resilience Ratio by Year (2009–2025)

Brooks Laboratories Limited asset resilience ratio by year from 2009 to 2025. The table below shows the annual Asset Resilience Ratio data for Brooks Laboratories Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	1.90%	Rs23.45 Million ≈ $253.55K	Rs1.24 Billion ≈ $13.38 Million	-0.68pp
2024-03-31	2.58%	Rs23.33 Million ≈ $252.31K	Rs904.45 Million ≈ $9.78 Million	+1.32pp
2023-03-31	1.26%	Rs13.78 Million ≈ $149.05K	Rs1.10 Billion ≈ $11.85 Million	-0.69pp
2022-03-31	1.94%	Rs38.10 Million ≈ $412.04K	Rs1.96 Billion ≈ $21.19 Million	+0.62pp
2021-03-31	1.32%	Rs21.41 Million ≈ $231.50K	Rs1.62 Billion ≈ $17.53 Million	+0.35pp
2020-03-31	0.97%	Rs15.28 Million ≈ $165.23K	Rs1.58 Billion ≈ $17.07 Million	-1.01pp
2019-03-31	1.98%	Rs33.17 Million ≈ $358.76K	Rs1.68 Billion ≈ $18.16 Million	+1.41pp
2018-03-31	0.56%	Rs9.67 Million ≈ $104.62K	Rs1.73 Billion ≈ $18.67 Million	+0.38pp
2017-03-31	0.18%	Rs2.86 Million ≈ $30.96K	Rs1.63 Billion ≈ $17.64 Million	+0.12pp
2010-03-31	0.05%	Rs200.00K ≈ $2.16K	Rs372.57 Million ≈ $4.03 Million	-0.01pp
2009-03-31	0.06%	Rs200.00K ≈ $2.16K	Rs321.19 Million ≈ $3.47 Million	--

pp = percentage points

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$20.86 Million

Rs1.93 Billion INR

Market Cap Rank

#24821 Global

#1373 in India

Share Price

Rs65.49

Change (1 day)

+1.44%

52-Week Range

Rs37.11 - Rs109.82

All Time High

Rs194.97